Patient characteristics at diagnosis by BMI
| . | Underweight/normal . | Overweight/obese . | P* . | ||
|---|---|---|---|---|---|
| Median (range) . | N (%) . | Median (range) . | N (%) . | ||
| All patients | — | 54 (100) | — | 90 (100) | |
| Age at diagnosis, y | 33 (1-76) | 50 (1-77) | |||
| ≤ 40 | — | 38 (70) | — | 31 (34) | < .0001 |
| > 40 | — | 16 (30) | — | 59 (66) | |
| Sex | |||||
| Male | — | 18 (33) | — | 48 (53) | .02 |
| Female | — | 36 (67) | — | 42 (47) | |
| French-American-British subtype | |||||
| Typical | — | 45 (83) | — | 75 (83) | 1.00 |
| Variant | — | 9 (17) | — | 15 (17) | |
| PML/RARα | |||||
| BCR1-2 | — | 32 (59) | — | 51 (57) | .76 |
| BCR3 | — | 22 (41) | — | 39 (43) | |
| WBC | 2.9 (0.4-77) | 2.4 (0.4-145) | |||
| ≤ 10 × 109/L | — | 41 (76) | — | 67 (74) | .84 |
| > 10 × 109/L | — | 13 (24) | — | 23 (26) | |
| Platelets | 29 (7-210) | 28.5 (8-196) | |||
| ≤ 40 × 109/L | — | 35 (65) | — | 63 (70) | .52 |
| > 40 × 109/L | — | 19 (35) | — | 27 (30) | |
| Hemoglobin | 9.2 (4-13.6) | 9.4 (5-15) | |||
| ≤ 10 g/dL | — | 36 (67) | — | 57 (63) | .69 |
| > 10 g/dL | — | 18 (33) | — | 33 (37) | |
| Sanz risk score | |||||
| Low | — | 14 (26) | — | 20 (22) | .78 |
| Intermediate | — | 27 (50) | — | 44 (49) | |
| High | — | 13 (24) | — | 26 (29) | |
| . | Underweight/normal . | Overweight/obese . | P* . | ||
|---|---|---|---|---|---|
| Median (range) . | N (%) . | Median (range) . | N (%) . | ||
| All patients | — | 54 (100) | — | 90 (100) | |
| Age at diagnosis, y | 33 (1-76) | 50 (1-77) | |||
| ≤ 40 | — | 38 (70) | — | 31 (34) | < .0001 |
| > 40 | — | 16 (30) | — | 59 (66) | |
| Sex | |||||
| Male | — | 18 (33) | — | 48 (53) | .02 |
| Female | — | 36 (67) | — | 42 (47) | |
| French-American-British subtype | |||||
| Typical | — | 45 (83) | — | 75 (83) | 1.00 |
| Variant | — | 9 (17) | — | 15 (17) | |
| PML/RARα | |||||
| BCR1-2 | — | 32 (59) | — | 51 (57) | .76 |
| BCR3 | — | 22 (41) | — | 39 (43) | |
| WBC | 2.9 (0.4-77) | 2.4 (0.4-145) | |||
| ≤ 10 × 109/L | — | 41 (76) | — | 67 (74) | .84 |
| > 10 × 109/L | — | 13 (24) | — | 23 (26) | |
| Platelets | 29 (7-210) | 28.5 (8-196) | |||
| ≤ 40 × 109/L | — | 35 (65) | — | 63 (70) | .52 |
| > 40 × 109/L | — | 19 (35) | — | 27 (30) | |
| Hemoglobin | 9.2 (4-13.6) | 9.4 (5-15) | |||
| ≤ 10 g/dL | — | 36 (67) | — | 57 (63) | .69 |
| > 10 g/dL | — | 18 (33) | — | 33 (37) | |
| Sanz risk score | |||||
| Low | — | 14 (26) | — | 20 (22) | .78 |
| Intermediate | — | 27 (50) | — | 44 (49) | |
| High | — | 13 (24) | — | 26 (29) | |
— indicates not applicable.
χ2 test comparing distributions among BMI groups.